ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity,supporting
SHENZHEN,China,Jan. 21,2025-- ZTE Corporation (0763.HK/000063.SZ),a global leading provider of integrated information and communication technology solutions,has been recognized as theoverall leader,t
Yanolja Platform and Interpark Triple unite to create a B2C mega-platform Maximizing platform synergy to pioneer a new path in the leisure and travel industries
~$304 Million of New Equity Capital to Support Deleveraging and Accelerate Company\'s Strategic Growth Initiatives
Availability ofDatabricks infrastructure in the Amazon Web Services\' (AWS) Asia Pacific (Jakarta) Region in early 2025
- Contributes Indonesian future talent education through education infrastructure improvement,teaching,and other programs
